Skip to content

Predicted values of propofol EC50 for gastroscope by BIS in female patients of different age

Predicted values of propofol EC50 for gastroscope by BIS in female patients of different age

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026825
Enrollment
Unknown
Registered
2019-10-23
Start date
2019-10-30
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroscope

Interventions

??1:Kirgiz adult patients > 65 years old
??2:Kirgiz adult patients 65 years old
??2:Uygurs adult patients 65 years old
??2:adult patients of Han nationality < 65 years old

Sponsors

The People's Hospital of Kizilsu Kirghiz Autonomous Prefecture
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Female patients undergoing painless gastroscopy, ASA I-II, BMI 18-27 kg/m2, no major mental or neurological disorders, no history of drug abuse, no severe respiratory and circulatory diseases, no history of alcohol addiction, and NYHA cardiac function grade 1 or 2 were selected.

Exclusion criteria

Exclusion criteria: Allergy to propofol or fat emulsion; Decompensated respiratory and circulatory, nervous system, liver and kidney dysfunction; BMI > 27 or < 18kg/m2; snoring; sleep apnea syndrome; hypoproteinemia < 30g/L; hemoglobin < 80g/L; progressive weight loss < 10kg; history of psychiatric and neurological disorders and related medications History: Preoperative alcoholism and refusal to participate.

Design outcomes

Primary

MeasureTime frame
the effective conc-entration for 50%;

Countries

China

Contacts

Public ContactCheng Wei

The People's Hospital of Kizilsu Kirghiz Autonomous Prefecture

53974314@qq.com+86 18796205791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026